Predicted to enable gap junction channel activity. Involved in several processes, including calcium ion transport; endothelium development; and response to pain. Located in gap junction. Part of connexin complex. Biomarker of ureteral obstruction. Human ortholog(s) of this gene implicated in coronary artery disease and myocardial infarction. Orthologous to human GJA4 (gap junction protein alpha 4); PARTICIPATES IN connexin signaling pathway; INTERACTS WITH (S)-nicotine; 1,2,4-trimethylbenzene; 1-naphthyl isothiocyanate.
connexin h1; connexin-37; cx37; CXN37; Cxnh1; gap junction alpha-4 protein; gap junction membrane channel protein alpha 4; Gap junction membrane channel protein alpha 4 (connexin 37); Gap junction membrane channel, protein alpha 4 (connexin 37)
[Estradiol co-treated with Progesterone] results in decreased expression of GJA4 mRNA and [Progesterone co-treated with Estradiol] results in decreased expression of GJA4 mRNA
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of GJA4 mRNA and [Diethylnitrosamine co-treated with Phenobarbital] results in decreased methylation of GJA4 promoter
[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of GJA4 mRNA and [Diethylnitrosamine co-treated with Phenobarbital] results in decreased methylation of GJA4 promoter
[Estradiol co-treated with Progesterone] results in decreased expression of GJA4 mRNA and [Progesterone co-treated with Estradiol] results in decreased expression of GJA4 mRNA
The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions.